William D Jones's most recent trade in Biogen Inc was a trade of 1,370 Common Stock done . Disclosure was reported to the exchange on June 15, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biogen | William D. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 1,370 | 2,145 (0%) | 0% | 0 | Common Stock | |
| DBA Sempra | William D. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 34 | 35,781 | - | - | Phantom Shares | |
| DBA Sempra | William D. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 94 | 35,461 | - | - | Phantom Shares | |
| DBA Sempra | William D. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 99 | 35,068 | - | - | Phantom Shares | |
| Biogen | William D. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 775 | 775 (0%) | 0% | 0 | Common Stock | |
| DBA Sempra | William D. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 93 | 34,679 | - | - | Phantom Shares | |
| DBA Sempra | William D. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2021 | 833 | 4,983 (0%) | 0% | 0 | Common Stock | |
| DBA Sempra | William D. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 94 | 34,311 | - | - | Phantom Shares | |
| DBA Sempra | William D. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 100 | 33,930 | - | - | Phantom Shares |